Abstract
The Taiwan Biobank (TWB) is an ongoing prospective study of over 150,000 individuals aged 30-70 recruited from across Taiwan beginning in 2012. A comprehensive list of phenotypes was collected for each consented participant at recruitment and follow-up visits through structured interviews and physical measurements. Biomarkers and genetic data were also generated for all participants from blood and urine samples. We present here an overview of the genetic data quality, population structure, and familial relationship within TWB, which consists of predominantly Han Chinese-ancestry individuals, and highlight important attributes and genetic findings thus far from the biobank. A linkage to Taiwan’s National Health Insurance database of >25 years and other health-related registries is underway that will enrich the phenotypic spectrum of TWB and enable deep and longitudinal genetic investigations. TWB provides one of the largest biobank resources for biomedical and public health research in East Asia that will contribute to our understanding of the genetic basis of human health and disease in global populations through collaborative studies with other biobanks.
Competing Interest Statement
Dr. Chia-Yen Chen is an employee of Biogen Inc. The other authors declare no conflict of interest.
Funding Statement
This research has been conducted using the Taiwan Biobank resource. We thank all the participants and investigators of the Taiwan Biobank. We thank the National Center for Genome Medicine of Taiwan for the technical support in genotyping. We thank the National Core Facility for Biopharmaceuticals (NCFB, MOST 106-2319-B-492-002) and National Center for High- performance Computing (NCHC) of National Applied Research Laboratories (NARLabs) of Taiwan for providing computational and storage resources. Y.F.L. is supported by the National Health Research Institutes (NP-109-PP-09; NP-110-PP-09) and the Ministry of Science and Technology (109-2314-B-400-017; 110-2314-B-400-028-MY3) of Taiwan. T.G. is supported by NIA K99/R00AG054573. H.H. acknowledges support from NIDDK K01DK114379, NIMH U01MH109539, Brain & Behavior Research Foundation Young Investigator Grant, the Zhengxu and Ying He Foundation, and the Stanley Center for Psychiatric Research. Y.A.F. and P.H.K. are supported by the "National Taiwan University Higher Education Sprout Project (NTU-110L8810)" within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan. YH.H. acknowledges support from NIAMS R01AR072199.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The access to and use of the Taiwan Biobank data in the present work was approved by the Ethics and Governance Council (EGC) of Taiwan Biobank (approval number: TWBR10907-05) and the Institutional Review Board (IRB) of National Health Research Institutes, Taiwan (approval number: EC1090402-E). The data collection of Taiwan Biobank was approved by the Ethics and Governance Council (EGC) of Taiwan Biobank and the Department of Health and Welfare, Taiwan (Wei-Shu-I-Tzu NO.1010267471). Taiwan Biobank obtained informed consent from all participants for research use of the collected data and samples.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data including individual genotypes and phenotypes of Taiwan Biobank (TWB) participants is available upon application for research purposes. A detailed description of TWB data availability and the application process can be found at https://taiwanview.twbiobank.org.tw/data_appl. In brief, investigators who are interested in obtaining the TWB data would need to submit an application that includes a detailed research proposal and an institutional review board (IRB) approval from the applicant's home institute to the TWB Data Release Group (contact email: biobank@gate.sinica.edu.tw). The application will go through scientific and ethical reviews by external experts in the relevant scientific fields and the Ethics and Governance Committee (EGC) of TWB. Once approved, researchers will be able to obtain the data for the approved research projects during the approved time period. For researchers who are interested in applying but reside outside of Taiwan, or any cross-country collaborations, an additional international data transfer agreement needs to be filed to the Ministry of Health and Welfare of Taiwan to enable sharing of the TWB individual-level data or any of its derivatives.
